Inside the Bloodstream: Micro-robots That Could Transform Stroke Treatment

By Emily Ma;

The Lawrenceville School, NJ

Imagine this: a robot, smaller than a grain of rice, navigating through your bloodstream straight to a life threatening blood clot. According to the American Heart Association’s 2024 report, strokes remain a major health concern as the fifth leading cause of deaths in the U.S. However, treating these blood clots poses a significant challenge because  the human vascular system is an intricate network of delicate blood vessels, leading to struggles for traditional catheter-based methods–threading a long, thin, flexible tube through a blood vessel from the arm, neck or groin–in reaching vessels that are narrow or distant. To address current limitations, researchers at Stanford developed the magnetic milli-spinner (M3bot), a miniature robot designed to navigate complex vascular networks. This emerging technology makes way for advancements in endovascular surgery by improving the precision and reach of blood clot removal.

In contrast to catheter-based tools, the M3bot is designed to navigate blood vessels without being constrained to a catheter. The robot has a hollow cylindrical body with helical fins and narrow slits. As the robot spins and an external magnetic field is applied, and while its helical structure uses the motion for forward propulsion. Additionally, the hollow interior and side slits of the robot generate a pressure difference that produces suction and propulsion efficiency. The overall design of the robot allows it to navigate complex networks of blood vessels while staying stable against strong blood flow. Once the robot reaches a blood clot, the spinning generates suction, which pulls the clot against the robot. It then compresses the blood clot’s internal mesh of protein fibers, which holds the blood cells together to reduce its volume so that it can be removed with the robot. In testing, the robot was able to compress 90-95% of the clot in approximately a minute.

M3bots also require precise identification of blood clots and navigation, which could be achieved through medical imaging and machine learning methods such as nuclear molecular imaging. Nuclear molecular imaging techniques that are able to target specific molecular components of blood clots, as explained in a 2026 review by Elhasnaoui, Robin, and Lemarie explain. Molecular imaging is able to show the biological composition and activity of a clot, which can help identify and classify blood clots. While traditional medical imaging could identify blood clots, machine-learning can be trained on medical images to guide navigation. Fully autonomous robots could minimize manual redirection, but require extremely precise localization and prevention against imaging errors or navigation errors and require further testing.

Despite the huge potential that these M3bots hold for endovascular surgery, there remain doubts regarding  patient safety, medical accessibility, and the limits of autonomous technology. Nonetheless, M3bots can provide additional approaches to treating obstructions that cannot be reached through conventional techniques. These bots are also minimally invasive, which creates an advantage when delicate and precise operation is needed. However, the introduction of robotic devices into blood streams carries risks such as damage to blood vessel walls, incomplete clot removal, and unintended movement if the robot fails to respond correctly to changing conditions. Beyond technical concerns, the mechanical design required to sustain these robots could make it expensive and inaccessible to hospitals with less resources. In addition, if artificial intelligence is incorporated, there are concerns for accountability in the case of emergency. In conclusion, incorporation of the M3bot depends not only on its capabilities but on real world testing, reliable safety measures, and equal access.

Works Cited

Elhasnaoui, J., Robin, P., & Lemarie, C. A. (2026). Nuclear molecular imaging of venous

thromboembolism: targeting clot-specific molecular components for improved diagnosis and management. Journal of thrombosis and haemostasis : JTH, 24(10), 3415–3431. https://doi.org/10.1016/j.jtha.2026.05.031

Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L.,

Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., Commodore-Mensah, Y., Currie, M. E., Elkind, M. S. V., Evenson, K. R., Generoso, G., Heard, D. G., Hiremath, S., Johansen, M. C., Kalani, R., Kazi, D. S., … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2024). 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation, 149(8), e347–e913. https://doi.org/10.1161/CIR.0000000000001209

Wu, S., Chang, Y., Leanza, S., Sim, J., Lu, L., Li, Q., Stone, D., & Zhao, R. R. (2026). Magnetic

Milli-Spinner for Robotic Endovascular Surgery. Advanced materials (Deerfield Beach, Fla.), 38(4), e08180. https://doi.org/10.1002/adma.202508180